These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 16628969

  • 21. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC, Maynard AD.
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The potential environmental impact of engineered nanomaterials.
    Colvin VL.
    Nat Biotechnol; 2003 Oct; 21(10):1166-70. PubMed ID: 14520401
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
    Warheit DB, Sayes CM, Reed KL, Swain KA.
    Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
    [Abstract] [Full Text] [Related]

  • 28. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.
    Bouwmeester H, Lynch I, Marvin HJ, Dawson KA, Berges M, Braguer D, Byrne HJ, Casey A, Chambers G, Clift MJ, Elia G, Fernandes TF, Fjellsbø LB, Hatto P, Juillerat L, Klein C, Kreyling WG, Nickel C, Riediker M, Stone V.
    Nanotoxicology; 2011 Mar; 5(1):1-11. PubMed ID: 21417684
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Conscious worst case definition for risk assessment, part I: a knowledge mapping approach for defining most critical risk factors in integrative risk management of chemicals and nanomaterials.
    Sørensen PB, Thomsen M, Assmuth T, Grieger KD, Baun A.
    Sci Total Environ; 2010 Aug 15; 408(18):3852-9. PubMed ID: 19945144
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV, Morgan H, Grassian VH, Brenner S.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012 Aug 15; 4(3):310-21. PubMed ID: 22131295
    [Abstract] [Full Text] [Related]

  • 36. [Health effects of engineered nanomaterials].
    Pietroiusti A, Magrini A, Bergamaschi A, Iavicoli I.
    G Ital Med Lav Ergon; 2010 Aug 15; 32(4 Suppl):287-9. PubMed ID: 21438282
    [Abstract] [Full Text] [Related]

  • 37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar 15; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nanotechnology safety concerns revisited.
    Stern ST, McNeil SE.
    Toxicol Sci; 2008 Jan 15; 101(1):4-21. PubMed ID: 17602205
    [Abstract] [Full Text] [Related]

  • 40. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C, Berges M, Chaudhry Q, Dusinska M, Fernandes TF, Olsen SI, Nowack B.
    Toxicology; 2010 Mar 10; 269(2-3):160-9. PubMed ID: 20025922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.